Neoplasm Metastasis: all 3,564 studies
Page 4 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsRecruitingNCT06835569Phase 1
- PROCARE - PROstate Cancer Real World Evidence RegistryRecruitingNCT06835218
- Ramadan Fasting Outcomes in Patients with Secondary Adrenal Insufficiency Before and After the Treatment of Hypotension.Not yet recruitingNCT06832566Phase 4
- Detection of Peritoneal Metastases by Diagnostic LAparoscopy in Patients With Locally Advanced Cervical CarcinomaNot yet recruitingNCT06832397
- Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRIRecruitingNCT06831357
- Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct AdenocarcinomaRecruitingNCT06831136Phase 2
- A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)RecruitingNCT06829147
- Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyRecruitingNCT06828588Early Phase 1
- Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal CancerRecruitingNCT06824064Phase 2
- Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID ProjectRecruitingNCT06821880
- Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid TumorsRecruitingNCT06821048Phase 1
- Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture CytologyRecruitingNCT06810349
- Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal MetastasisRecruitingNCT06809517Phase 1/2
- Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell DeviceRecruitingNCT06807502Not applicable
- Biomolecular Markers of Bone MetastasisRecruitingNCT06806462Not applicable
- A Study of BGB-B455 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06803680Phase 1
- Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS PatientsAvailableNCT06802328
- BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADCRecruitingNCT06793332Phase 2
- The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell TransplantationRecruitingNCT06792682Phase 1
- Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaRecruitingNCT06790602Phase 2
- Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide StudyRecruitingNCT06787014
- Laparoscopic Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) for Colorectal Liver Metastases (CRLM)Not yet recruitingNCT06779474
- A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationRecruitingNCT06778863Phase 1
- Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II TrialRecruitingNCT06778408Phase 2
- SLV-154 Treatment of Advanced CancersRecruitingNCT06771219Phase 1
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaRecruitingNCT06769698Phase 2
- Part of the Modern Art StudyNot yet recruitingNCT06768242Not applicable
- Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIsNot yet recruitingNCT06766591Not applicable
- Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,RecruitingNCT06762483
- Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)RecruitingNCT06757634Phase 3
- Evaluate the Efficacy of Radiofrequency Ablation/Vertebroplasty with or Without SBRT for Treating Painful Spinal Vertebral MetastasesNot yet recruitingNCT06756087Not applicable
- CT-95 in Advanced Cancers Associated With Mesothelin ExpressionRecruitingNCT06756035Phase 1
- RELIEVE: Research on Effectiveness of Surgery and Radiotherapy on Relieving Spine Tumor Pain in Patients with Vertebral MetastasesNot yet recruitingNCT06746103
- Study of HRS-2189 Combined HRS-5041 in Prostate CancerNot yet recruitingNCT06738745Phase 2
- Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer PatientsNot yet recruitingNCT06729099
- Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast CancerNot yet recruitingNCT06728150
- Study of ISM5939 in Patients With Advanced and/or Metastatic Solid TumorsNot yet recruitingNCT06724042Phase 1
- A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).Not yet recruitingNCT06719479Phase 2/3
- A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in ChinaRecruitingNCT06718972
- Study of SHR-A1811 Combined with Pyrotinib and Bevacizumab in Advanced Breast Cancer with Brain MetastasisRecruitingNCT06718933Phase 1/2
- Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.Not yet recruitingNCT06716775Not applicable
- AZD5305 hADME in Patients With Advanced Solid MalignanciesRecruitingNCT06713369Phase 1
- Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic StatusRecruitingNCT06713161
- Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central LungRecruitingNCT06712745Early Phase 1
- Retrospective Study on Leptomeningeal Metastasis of Solid TumorsEnrolling by invitationNCT06705049
- Risk Model for Metastasis Detection of NeuroblastomaEnrolling by invitationNCT06703944
- Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain MetastasesRecruitingNCT06702826Phase 2
- Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.RecruitingNCT06700057
- Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.RecruitingNCT06697301Phase 2/3
- Axillary LNs Evalution in Breast Cancer by Multimodal UsNot yet recruitingNCT06695052
- A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With CancerRecruitingNCT06693687Not applicable
- Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease PatientsRecruitingNCT06690970
- Somatostatin Receptor PET/CT in SSTR-Related Disease PatientsRecruitingNCT06690957
- Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related DiseasesRecruitingNCT06690736Not applicable
- FAPI PET/CT in Various FAP-Related Disease PatientsRecruitingNCT06688071
- A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid TumorsRecruitingNCT06687941Phase 1
- A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal MetastasisRecruitingNCT06685887Phase 2
- Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung CancerRecruitingNCT06684418
- Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain MetastasesNot yet recruitingNCT06683703Phase 2
- Tislelizumab Combined with SOX and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Metastasis: a Prospective Cohort StudyNot yet recruitingNCT06682182
- Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)Not yet recruitingNCT06681038Phase 2
- A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic TherapyNot yet recruitingNCT06680258Phase 3
- Study of SYN818 for the Treatment of Advanced or Metastatic Solid TumorsRecruitingNCT06666270Phase 1
- Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.Not yet recruitingNCT06660862Phase 4
- A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsRecruitingNCT06657144Phase 1
- Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal MetastasisRecruitingNCT06643000Not applicable
- Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGDRecruitingNCT06638034Early Phase 1
- Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)RecruitingNCT06634875Phase 2
- Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid TumorsRecruitingNCT06630416Phase 2
- Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsRecruitingNCT06625775Phase 1
- The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal CancerNot yet recruitingNCT06609434Not applicable
- Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid CancersRecruitingNCT06606990Phase 1
- Branched Chained Amino Acid Supplement in Patients Undergoing Lower Limb Bone Cancer Curettage for Bone MetastasisNot yet recruitingNCT06604910Not applicable
- Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney CancerRecruitingNCT06601296Phase 2
- The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)RecruitingNCT06601075
- The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.RecruitingNCT06597526
- Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal CancerNot yet recruitingNCT06593548Phase 2
- A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLMRecruitingNCT06590259Phase 2
- Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With ChemotherapyRecruitingNCT06587295Phase 1
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsRecruitingNCT06586957Phase 1
- A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaRecruitingNCT06581406Phase 2/3
- A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver MetastasesRecruitingNCT06567353Not applicable
- Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid TumorsRecruitingNCT06566079Phase 1/2
- The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular HemorrhageRecruitingNCT06563817Phase 2
- A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06561685Phase 1
- DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver MetastasesRecruitingNCT06555003Phase 3
- ElastoMRI Evaluation of Hepatic Metastases in Colorectal Cancer ( MetaIRM)Not yet recruitingNCT06552117Not applicable
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06545942Phase 1
- A Study for Dynamic Prediction Model of Breast Cancer Bone MetastasesNot yet recruitingNCT06544668
- NON-COlorectal Liver METastases Undergoing Liver ResectionNot yet recruitingNCT06542926
- Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast CancerNot yet recruitingNCT06539559Phase 2
- Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical StudyRecruitingNCT06538896Phase 2
- Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial CarcinomaRecruitingNCT06532539Phase 2
- A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung CancerNot yet recruitingNCT06525350Phase 2
- Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound HistotripsyRecruitingNCT06524570Phase 1
- Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung CancerRecruitingNCT06523673Phase 3
- The Role of Short Course of Palliative Radiation in Metastatic Cancer RectumNot yet recruitingNCT06521827Not applicable
- A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)RecruitingNCT06521554Phase 1
- PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver MetastasesRecruitingNCT06519266Phase 3
- Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia VeraRecruitingNCT06516406